Cargando…
Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells
Despite prophylactic vaccination campaigns, high-risk human papillomavirus (HPV)-induced cervical cancer remains a significant health threat among women, especially in developing countries. The initial occurrence and consequent progression of this cancer type primarily rely on, E6 and E7, two key vi...
Autores principales: | Zhu, Jinshun, Kamara, Saidu, Wang, Qi, Guo, Yanru, Li, Qingfeng, Wang, Linlin, Chen, Jingjing, Du, Qianqian, Du, Wangqi, Chen, Shao, Zhu, Shanli, Chen, Jun, Chu, Maoping, Zhang, Lifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181454/ https://www.ncbi.nlm.nih.gov/pubmed/34109181 http://dx.doi.org/10.3389/fcell.2021.677867 |
Ejemplares similares
-
Generation of affibody molecules specific for HPV16 E7 recognition
por: Xue, Xiangyang, et al.
Publicado: (2016) -
Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants
por: Du, Wangqi, et al.
Publicado: (2022) -
Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells
por: Zhu, Jinshun, et al.
Publicado: (2020) -
Correction: Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells
por: Zhu, Jinshun, et al.
Publicado: (2020) -
Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
por: Kamara, Saidu, et al.
Publicado: (2023)